China+1 strategy gains momentum in pharma, but full monetisation still 2-3 years away: Goldman Sachs
Jun 25, 2025
Indian pharmaceutical and biotech sectors have started witnessing tangible benefits from the global shift away from China, as early signs of the China+1 strategy...